1. Home
  2. ROIC vs RCKT Comparison

ROIC vs RCKT Comparison

Compare ROIC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIC
  • RCKT
  • Stock Information
  • Founded
  • ROIC 2007
  • RCKT 1999
  • Country
  • ROIC United States
  • RCKT United States
  • Employees
  • ROIC N/A
  • RCKT N/A
  • Industry
  • ROIC Real Estate Investment Trusts
  • RCKT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROIC Real Estate
  • RCKT Health Care
  • Exchange
  • ROIC Nasdaq
  • RCKT Nasdaq
  • Market Cap
  • ROIC 2.0B
  • RCKT 1.9B
  • IPO Year
  • ROIC N/A
  • RCKT N/A
  • Fundamental
  • Price
  • ROIC $16.59
  • RCKT $17.19
  • Analyst Decision
  • ROIC Hold
  • RCKT Strong Buy
  • Analyst Count
  • ROIC 4
  • RCKT 9
  • Target Price
  • ROIC $14.00
  • RCKT $53.22
  • AVG Volume (30 Days)
  • ROIC 671.7K
  • RCKT 619.5K
  • Earning Date
  • ROIC 10-22-2024
  • RCKT 11-12-2024
  • Dividend Yield
  • ROIC 3.62%
  • RCKT N/A
  • EPS Growth
  • ROIC 57.91
  • RCKT N/A
  • EPS
  • ROIC 0.46
  • RCKT N/A
  • Revenue
  • ROIC $336,785,000.00
  • RCKT N/A
  • Revenue This Year
  • ROIC N/A
  • RCKT N/A
  • Revenue Next Year
  • ROIC $0.75
  • RCKT $382.35
  • P/E Ratio
  • ROIC $36.09
  • RCKT N/A
  • Revenue Growth
  • ROIC 4.18
  • RCKT N/A
  • 52 Week Low
  • ROIC $11.80
  • RCKT $15.98
  • 52 Week High
  • ROIC $17.17
  • RCKT $32.53
  • Technical
  • Relative Strength Index (RSI)
  • ROIC 65.49
  • RCKT 47.06
  • Support Level
  • ROIC $15.12
  • RCKT $16.48
  • Resistance Level
  • ROIC $17.17
  • RCKT $17.75
  • Average True Range (ATR)
  • ROIC 0.37
  • RCKT 0.73
  • MACD
  • ROIC 0.07
  • RCKT 0.02
  • Stochastic Oscillator
  • ROIC 71.71
  • RCKT 38.63

About ROIC Retail Opportunity Investments Corp. (MD)

Retail Opportunity Investments Corp is a self-managed real estate investment trust. The company specializes in the acquisition, ownership and management of necessity-based community and neighborhood shopping centers on the west coast of the United States, anchored by supermarkets and drugstores. The Company's primary business is the ownership, management, and redevelopment of retail real estate properties.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

Share on Social Networks: